Precision Biologics, Inc. announces in vitro and in vivo efficacy of its novel tumor-specific ADC (PB-vcMMAE-5) against human carcinomas expressing truncated core 2 O-glycans. Recent data for several ...

Thank you, operator. Good morning and good afternoon, everybody, and thank you for joining BioNTech's Third Quarter 2025 Earnings Call. As a reminder, the slides we'll use during the call and the ...

A former member of the House of Representatives and ex-Senior Special Assistant to the President on National Assembly Matters ...

Tommy Rittenhouse had a touchdown pass and a touchdown run to guide Illinois State to a 31-16 victory over Northern Iowa on Saturday.

The official source for NFL news, video highlights, fantasy football, game-day coverage, schedules, stats, scores and more.

Global Cancer Antibody Drug Conjugates Market Opportunity USD 70 Billion Opportunty By 2031Delhi, Oct. 30, 2025 (GLOBE ...

If you've ever thought about gut support, you're not alone. In fact, nearly 75% of U.S. adults experience digestive ...

BOSTON and LONDON, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology ...

Antibody-drug conjugates (ADCs) represent a new era in cancer therapy, harnessing the precision of antibodies to deliver ...

Nwosu appealed to voters across the state to turn out en masse on election day and reject inducements from any political camp.

Thousand Oaks Biologics, a leading Asia-based CRDMO specializing in macromolecules, today announced its participation in CPHI Frankfurt 2025, held from October 28-30.

Piper Sandler lowered the firm’s price target on F5 (FFIV) to $277 from $355 and keeps a Neutral rating on the shares. The ...